Open AccessFREQUENCY OF OCCURRENCE OF RISK FACTORS AND ADHERENCE TO DRUG THERAPY IN YAKUTS WHO UNDERWENT Q-POSITIVE MYOCARDIAL INFARCTION
Author(s) -
Е. С. Кылбанова,
Ekaterina V. Gur’eva,
Anna Pavlova
Publication year - 2018
Publication title -
arhivʺ vnutrennej mediciny
Language(s) - English
Resource type - Journals
eISSN - 2411-6564
pISSN - 2226-6704
DOI - 10.20514/2226-6704-2018-8-4-291-299
Subject(s) - medicine , myocardial infarction , incidence (geometry) , clopidogrel , cardiology , risk factor , decompensation , blood pressure , medical prescription , pharmacology , physics , optics
The aim of the article was to study for 12 months the adherence to drug therapy and the incidence of cardiovascular risk factors in Yakutia patients who underwent Q-positive myocardial infarction. Materials and methods . The analysis included 113 patients from Yakutsk with Q-positive acute myocardial infarction, the average age is 59 [51;64] years old. Results . The following conclusions are obtained: The majority of patients of Yakut nationality who underwent Q-positive myocardial infarction have a high incidence of cardiovascular risk factors. Among the examined patients of this category after 6 months was received a low adherence to prescription drugs: clopidogrel /ticagrelor (by 9.9%), ACE inhibitors / sartans (by 18%), β-adrenoblockers (by 24.6%), statins (by 46.7%). For the 12th month after a second consultation, there was an increased adherence to taking the statins by 33.3% and beta-blockers by 17.8%. AH is a well-controlled risk factor, in most patients there is an effective reduction in high blood pressure values from the first months. The mean of total cholesterol, cholesnerol — LDL and the frequency of hypercholesterinemia, hypercholesterinemia LDL for 12 months after a recent MI is decreased, but the target values were not achieved due to low adherence to taking statins. Conclusion . Due to the low adherence to drug therapy and the insufficient correction of risk factors for CVD after MI there was noted repeated hospitalizations for repeated ACS, decompensation of CHF, and fatal cases/outcomes, regardless of ethnicity, which requires intensification of the measures for dispenserization, at the primary level health.